Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 26A101 | MRT-8102 | 3069891-91-1 | ≧98.0% |  |
| MRT-6160 (DDY391) is a potent, highly selective, and orally bioavailable investigatio | ||||
| 26A100 | MRT-6160 | 3050683-38-7 | ≧98.0% |  |
| MRT-6160 is a highly selective first-in-class oral VAV1-targeting molecular glue degr | ||||
| 26A099 | MRT-2359 | 2803881-11-8 | ≧98.0% |  |
| MRT-2359 is a potent, highly selective, and orally bioavailable investigational molec | ||||
| 26A098 | EA1080 (Synonyms: NSHO-101) | 2122780-15-6 | ≧98.0% |  |
| Emvistegrast (GS-1427) is an investigational oral α4β7 integrin inhibitor. | ||||
| 26A097 | Emvistegrast (Synonyms: GS-1427) | 2417352-91-9 | ≧98.0% | _2417352-91-9.png) |
| Emvistegrast (GS-1427) is an investigational oral α4β7 integrin inhibitor. | ||||
| 26A094 | Sonlicromanol (Synonyms: KH176) | 1541170-75-5 | ≧98.0% |  |
| Sonlicromanol is a reductive and oxidative distress modulator with anti-inflammatory | ||||
| 26A093 | Engasertib (Synonyms: ALM301) | 1313439-71-2 | ≧98.0% | _1313439-71-2.png) |
| Engasertib (previously known as ALM 301) is a small molecule, selective allosteric AK | ||||
| 26A096 | Ontunisertib (Synonyms: AGMB-129) | 2647949-48-0 | ≧98.0% |  |
| Ontunisertib (also known as AGMB-129) is an investigational, oral, gastrointestinal-r | ||||
| 26A095 | VRN110755 | 2869090-93-5 | ≧98.0% |  |
| VRN110755 is an orally available, highly selective EGFR inhibitor. | ||||
| 26A091 | Pozdeutinurad (Synonyms: AR882) | 2173408-41-6 | ≧98.0% | _2173408-41-6.png) |
| Pozdeutinurad, also known as AR 882, is a small molecule, URAT1 (SLC22A12) inhibitor. | ||||
| 26A090 | Budiodarone (Synonyms: ATI-2042) | 335148-45-3 | ≧98.0% | _335148-45-3.png) |
| Budiodarone (ATI-2042) is an antiarrhythmic agent and chemical analog of amiodarone.I | ||||
| 26A089 | Linafexor (Synonyms: CS-0159) | 2765593-43-7 | ≧98.0% | _2765593-43-7.png) |
| Linafexor (Synonyms: CS-0159) is a potent non-bile-acid agonist of the farnesoid X re | ||||